Study of two drugs for angina treatment shows equal outcomes to patients
|
Tweet
|
|
Researchers have found that the blood-thinning drug Lovenox works as well as a standard artery-clearing drug in patients with severe heart-related chest pain, but neither reduced the risk of death after a year of treatment.
The study, funded by drug company Aventis Pharmaceuticals which makes Lovenox, involved nearly 10,000 patients at 487 hospitals in 12 countries who suffered from acute coronary syndromes such as severe angina that cannot be treated with surgery or Angioplasty .
The patients had all undergone revascularization, a treatment in which small holes are laser-drilled in the heart tissue to improve blood flow.
In the study, which was over a year, the patients were treated with either enoxaparin, the generic name for Lovenox, or a form of heparin, the standard medicine used in many hospitals for artery-clearing.
According to the report from the Duke Clinical Research Institute, in Durham, North Carolina, after one year the death rates in the two treatment groups were similar.
The researchers concluded that high-risk patients with acute coronary syndromes remain susceptible to continued cardiac events despite aggressive therapies.
The report is published in the current edition of the Journal of the American Medical Association.
Revision date: July 9, 2011
Last revised: by Dave R. Roger, M.D.
 |
 |
 |
 | ||
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
